共 50 条
- [42] INHIBITION OF CONSTITUTIVELY ACTIVE STAT3 REVERSES ENZALUTAMIDE RESISTANCE IN LNCAP DERIVATIVE PROSTATE CANCER CELLS JOURNAL OF UROLOGY, 2014, 191 (04): : E262 - E262
- [44] Inhibition of Constitutively Active Stat3 Reverses Enzalutamide Resistance in LNCaP Derivative Prostate Cancer Cells PROSTATE, 2014, 74 (02): : 201 - 209
- [46] Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway Archives of Toxicology, 2015, 89 : 121 - 136